Table 4 Subgroup Analysis for Cardiovascular Mortality Associated with aTRH
N | Deaths | Any aTRH vs. Controlled | p-interaction | |
|---|---|---|---|---|
Age (years) | ||||
< 45 years | 579 | 15 | NA | 0.211 |
45–65 years | 2511 | 117 | 2.13 (1.18, 3.88) | |
≥ 65 years | 3267 | 418 | 1.23 (0.91, 1.66) | |
Sex | ||||
Female | 3426 | 269 | 1.87 (1.26, 2.79) | 0.033 |
Male | 2931 | 281 | 1.13 (0.76, 1.69) | |
Race/Ethnicity | ||||
Non-Hispanic White | 3432 | 343 | 1.56 (1.13, 2.15) | |
Non-Hispanic Black | 1712 | 143 | 1.17 (0.73, 1.88) | 0.583 |
Mexican American | 1033 | 58 | 1.15 (0.38, 3.43) | |
Other | 180 | 6 | NA | |
Nonsmoker | 2869 | 218 | 2.16 (1.34, 3.47) | 0.075 |
Smoker | 3481 | 332 | 1.19 (0.85, 1.65) | |
No Diabetes | 4237 | 349 | 1.48 (1.05, 2.07) | 0.746 |
Diabetes | 2120 | 201 | 1.46 (0.94, 2.28) | |
No CVD | 4558 | 261 | 1.68 (1.1, 2.56) | 0.03 |
CVD | 1737 | 282 | 1.35 (1, 1.81) | |
No Diuretic | 2714 | 161 | 1.223 (0.62, 2.4) | 0.818 |
Diuretic | 3643 | 389 | 1.48 (1.04, 2.11) | |
No ACE-I or ARB | 1705 | 101 | 1.35 (0.69, 2.62) | 0.562 |
ACE-I or ARB | 3678 | 260 | 1.7 (1.18, 2.44) | |
No CCBb | 4117 | 303 | 1.54 (0.98, 2.43) | 0.549 |
CCBb | 2240 | 247 | 1.35 (0.93, 1.98) | |
No Betablocker | 3811 | 309 | 1.51 (1.03, 2.22) | 0.411 |
Betablocker | 2546 | 241 | 1.4 (0.91, 2.16) | |
No Antihtn_otherc | 5252 | 411 | 1.41 (0.98, 2.01) | 0.649 |
Antihtn_otherc | 1105 | 139 | 1.55 (0.89, 2.69) | |
eGFR CKDEPI Categoriesa | ||||
≥ 120 | 135 | 5 | NA | 0.521 |
90–119 | 1617 | 47 | 1.6 (0.57, 4.47) | |
60–89 | 2677 | 215 | 1.34 (0.88, 2.04) | |
45–59 | 929 | 129 | 1.94 (1.17, 3.2) | |
30–44 | 417 | 76 | 1.08 (0.47, 2.47) | |
< 30 | 187 | 38 | 2.33 (0.32, 16.86) | |
CRP (mg/dL) | ||||
< 0.22 | 2546 | 220 | 1.18 (0.76, 1.84) | 0.582 |
0.22–0.99 | 2487 | 187 | 1.74 (1.16, 2.6) | |
≥ 1.00 | 981 | 109 | 2.17 (0.99, 4.77) | |
ACR | ||||
< 30 | 4807 | 310 | 1.79 (1.27, 2.52) | 0.063 |
30–300 | 1061 | 142 | 1.31 (0.83, 2.07) | |
≥ 300 | 292 | 57 | 0.93 (0.43, 2) | |